Financials
- Market Capitalization 21.96 M
- Employee 10
- Founded 2006
- CEO N/A
- Website www.cocrystalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000V27360
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4535 | JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.69 USD | -1.43% | -4.17% | +9.52% | -75.70% | 22.96 M USD | ||
| 4536 | ENLV Enlivex Ltd. - Ordinary Shares | 1.35 USD | -8.78% | -8.16% | -41.05% | +29.81% | 21.36 M USD | ||
| 4549 | LGVN Longeveron Inc. - Class A Common stock | 6.72 USD | -1.18% | +700.00% | +1001.64% | +1076.26% | 21.42 M USD | ||
| 4563 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.76 USD | -0.27% | -3.59% | -2.34% | -70.09% | 20.32 M USD |
Frequently asked questions about Cocrystal Pharma, Inc. Common Stock
What is the Cocrystal Pharma, Inc. Common Stock stock price today?
The current price of Cocrystal Pharma, Inc. Common Stock (COCP) is 1.14. Over the past 24 hours, the stock has changed by 0.00%. Follow the COCP chart for real-time price dynamics.
What is the stock ticker of Cocrystal Pharma, Inc. Common Stock?
Cocrystal Pharma, Inc. Common Stock trades under the ticker COCP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cocrystal Pharma, Inc. Common Stock stock going up?
COCP has changed by 0.00% over the last week, +22.58% over the last month, and -26.92% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Cocrystal Pharma, Inc. Common Stock?
Cocrystal Pharma, Inc. Common Stock currently has a market capitalization of 21.96 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Cocrystal Pharma, Inc. Common Stock earnings last quarter?
Last quarter, Cocrystal Pharma, Inc. Common Stock reported earnings of -0.23 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Cocrystal Pharma, Inc. Common Stock revenue for the last quarter?
Cocrystal Pharma, Inc. Common Stock reported quarterly revenue of 105 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Cocrystal Pharma, Inc. Common Stock net income for the last quarter?
Cocrystal Pharma, Inc. Common Stock reported net income of -3.16 M for the last quarter. The previous quarter showed -2.3 M, which means net income changed by -37.63%.
How many employees does Cocrystal Pharma, Inc. Common Stock have?
As of the latest available data, Cocrystal Pharma, Inc. Common Stock has 10 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Cocrystal Pharma, Inc. Common Stock stock?
You can buy Cocrystal Pharma, Inc. Common Stock (COCP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cocrystal Pharma, Inc. Common Stock stock?
Investing in Cocrystal Pharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the COCP chart and related analysis on metatrader.com as part of your research.